Skip to main content

Advertisement

SpringerLink
Log in

Comprehensive plaque assessment with serial coronary CT angiography: translation to bedside

  • Review Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

The purpose of this review is to highlight the utility of comprehensive plaque assessment by serial coronary computed tomography angiography (CCTA) to understand atherosclerosis and its effect on cardiovascular risk stratification and management. CCTA is a validated, noninvasive imaging modality for coronary atherosclerotic plaque characterization. Numerous clinical trials have used approach of serial CCTA to demonstrate the potential benefits of multiple treatment strategies to reduce coronary plaque progression and its translation to benefits with cardiovascular outcomes. Serial CCTA trials for cardiovascular therapies combined with clinical outcome studies are providing mechanistic correlations of coronary atherogenesis and cardiovascular risk reduction, thereby establishing a new standard of care in addressing cardiac disease. Advancements in CCTA imaging and plaque analysis continue to expand the potential for CCTA in the evaluation of cardiovascular risk and targeted treatment of CAD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Arbab-Zadeh A, Fuster V (2019) From detecting the vulnerable plaque to managing the vulnerable patient: JACC state-of-the-art Review. J Am Coll Cardiol 74(12):1582–1593

    Article  PubMed  Google Scholar 

  2. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20(5):1262–1275

    Article  CAS  PubMed  Google Scholar 

  3. Glaser R, Selzer F, Faxon DP, Laskey WK, Cohen HA, Slater J, Detre KM, Wilensky RL (2005) Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 111(2):143–149

    Article  PubMed  Google Scholar 

  4. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V (1988) Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12(1):56–62

    Article  CAS  PubMed  Google Scholar 

  5. Hadamitzky M, Achenbach S, Al-Mallah M, Berman D, Budoff M, Cademartiri F, Callister T, Chang HJ, Cheng V, Chinnaiyan K, Chow BJ, Cury R, Delago A, Dunning A, Feuchtner G, Gomez M, Kaufmann P, Kim YJ, Leipsic J, Lin FY, Maffei E, Min JK, Raff G, Shaw LJ, Villines TC, Hausleiter J (2013) Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry). J Am Coll Cardiol 62(5):468–476

    Article  PubMed  Google Scholar 

  6. van den Hoogen IJ, van Rosendael AR, Lin FY, Lu Y, Dimitriu-Leen AC, Smit JM, Scholte A, Achenbach S, Al-Mallah MH, Andreini D, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJW, Cury RC, DeLago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Leipsic JA, Maffei E, Marques H, de Araujo Goncalves P, Pontone G, Raff GL, Rubinshtein R, Villines TC, Gransar H, Jones EC, Pena JM, Shaw LJ, Min JK, Bax JJ (2019) Coronary atherosclerosis scoring with semiquantitative CCTA risk scores for prediction of major adverse cardiac events: Propensity score-based analysis of diabetic and non-diabetic patients. J Cardiovasc Comput Tomogr. https://doi.org/10.1016/j.jcct.2019.11.015

  7. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356(15):1503–1516

    Article  CAS  PubMed  Google Scholar 

  8. Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360(24):2503–2515

    Article  CAS  PubMed  Google Scholar 

  9. Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Alexander KP, Senior R, Boden WE, Stone GW, Goodman SG, Lopes RD, Lopez-Sendon J, White HD, Maggioni AP, Shaw LJ, Min JK, Picard MH, Berman DS, Chaitman BR, Mark DB, Spertus JA, Cyr DD, Bhargava B, Ruzyllo W, Wander GS, Chernyavskiy AM, Rosenberg YD, Maron DJ (2019) Baseline characteristics and risk profiles of participants in the ISCHEMIA randomized clinical trial. JAMA Cardiol 4(3):273–286

    Article  PubMed  PubMed Central  Google Scholar 

  10. Dahal S, Budoff MJ (2019) Implications of serial coronary computed tomography angiography in the evaluation of coronary plaque progression. Curr Opin Lipidol 30(6):446–451

    Article  CAS  PubMed  Google Scholar 

  11. Matsumoto H, Watanabe S, Kyo E, Tsuji T, Ando Y, Otaki Y, Cadet S, Gransar H, Berman DS, Slomka P, Tamarappoo BK, Dey D (2019) Standardized volumetric plaque quantification and characterization from coronary CT angiography: a head-to-head comparison with invasive intravascular ultrasound. Eur Radiol 29(11):6129–6139

    Article  PubMed  PubMed Central  Google Scholar 

  12. Achenbach S, Boehmer K, Pflederer T, Ropers D, Seltmann M, Lell M, Anders K, Kuettner A, Uder M, Daniel WG, Marwan M (2010) Influence of slice thickness and reconstruction kernel on the computed tomographic attenuation of coronary atherosclerotic plaque. J Cardiovasc Comput Tomogr 4(2):110–115

    Article  PubMed  Google Scholar 

  13. Cademartiri F, Mollet NR, Runza G, Bruining N, Hamers R, Somers P, Knaapen M, Verheye S, Midiri M, Krestin GP, de Feyter PJ (2005) Influence of intracoronary attenuation on coronary plaque measurements using multislice computed tomography: observations in an ex vivo model of coronary computed tomography angiography. Eur Radiol 15(7):1426–1431

    Article  PubMed  Google Scholar 

  14. Dalager MG, Bottcher M, Dalager S, Andersen G, Thygesen J, Pedersen EM, Botker HE (2011) Imaging atherosclerotic plaques by cardiac computed tomography in vitro: impact of contrast type and acquisition protocol. Invest Radiol 46(12):790–795

    Article  PubMed  Google Scholar 

  15. Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347):317–325

    Article  CAS  PubMed  Google Scholar 

  16. Tabas I, Williams KJ, Boren J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116(16):1832–1844

    Article  CAS  PubMed  Google Scholar 

  17. Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114(12):1852–1866

    Article  CAS  PubMed  Google Scholar 

  18. Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, Strauss HW (2017) Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc Imaging 10(5):582–593

    Article  PubMed  Google Scholar 

  19. Marwan M, Taher MA, El Meniawy K, Awadallah H, Pflederer T, Schuhback A, Ropers D, Daniel WG, Achenbach S (2011) In vivo CT detection of lipid-rich coronary artery atherosclerotic plaques using quantitative histogram analysis: a head to head comparison with IVUS. Atherosclerosis 215(1):110–115

    Article  CAS  PubMed  Google Scholar 

  20. Maurovich-Horvat P, Ferencik M, Voros S, Merkely B, Hoffmann U (2014) Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol 11(7):390–402

    Article  PubMed  Google Scholar 

  21. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, Inoue K, Okumura M, Ishii J, Anno H, Virmani R, Ozaki Y, Hishida H, Narula J (2007) Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 50(4):319–326

    Article  PubMed  Google Scholar 

  22. Kashiwagi M, Tanaka A, Shimada K, Kitabata H, Komukai K, Nishiguchi T, Ozaki Y, Tanimoto T, Kubo T, Hirata K, Mizukoshi M, Akasaka T (2013) Distribution, frequency and clinical implications of napkin-ring sign assessed by multidetector computed tomography. J Cardiol 61(6):399–403

    Article  PubMed  Google Scholar 

  23. Puchner SB, Liu T, Mayrhofer T, Truong QA, Lee H, Fleg JL, Nagurney JT, Udelson JE, Hoffmann U, Ferencik M (2014) High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol 64(7):684–692

    Article  PubMed  PubMed Central  Google Scholar 

  24. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah MH, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan KM, Chow B, Delago A, Hadamitzky M, Hausleiter J, Karlsberg RP, Kaufmann P, Maffei E, Nasir K, Pencina MJ, Raff GL, Shaw LJ, Villines TC (2011) Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry. J Cardiovasc Comput Tomogr 5(2):84–92

    Article  PubMed  Google Scholar 

  25. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R (1995) Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 92(7):1701–1709

    Article  CAS  PubMed  Google Scholar 

  26. van Velzen JE, de Graaf FR, de Graaf MA, Schuijf JD, Kroft LJ, de Roos A, Reiber JH, Bax JJ, Jukema JW, Boersma E, Schalij MJ, van der Wall EE (2011) Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis. J Nucl Cardiol 18(5):893–903

    Article  PubMed  PubMed Central  Google Scholar 

  27. Pflederer T, Marwan M, Schepis T, Ropers D, Seltmann M, Muschiol G, Daniel WG, Achenbach S (2010) Characterization of culprit lesions in acute coronary syndromes using coronary dual-source CT angiography. Atherosclerosis 211(2):437–444

    Article  CAS  PubMed  Google Scholar 

  28. Kitagawa T, Yamamoto H, Horiguchi J, Ohhashi N, Tadehara F, Shokawa T, Dohi Y, Kunita E, Utsunomiya H, Kohno N, Kihara Y (2009) Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging 2(2):153–160

    Article  PubMed  Google Scholar 

  29. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316(22):1371–1375

    Article  CAS  PubMed  Google Scholar 

  30. Varnava AM, Mills PG, Davies MJ (2002) Relationship between coronary artery remodeling and plaque vulnerability. Circulation 105(8):939–943

    Article  PubMed  Google Scholar 

  31. Achenbach S, Ropers D, Hoffmann U, MacNeill B, Baum U, Pohle K, Brady TJ, Pomerantsev E, Ludwig J, Flachskampf FA, Wicky S, Jang IK, Daniel WG (2004) Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. J Am Coll Cardiol 43(5):842–847

    Article  PubMed  Google Scholar 

  32. Motoyama S, Sarai M, Narula J, Ozaki Y (2013) Coronary CT angiography and high-risk plaque morphology. Cardiovasc Interv Ther 28(1):1–8

    Article  CAS  PubMed  Google Scholar 

  33. Conte E, Mushtaq S, Pontone G, Li Piani L, Ravagnani P, Galli S, Collet C, Sonck J, Di Odoardo L, Guglielmo M, Baggiano A, Trabattoni D, Annoni A, Mancini ME, Formenti A, Muscogiuri G, Magatelli M, Nicoli F, Poggi C, Fiorentini C, Bartorelli AL, Pepi M, Montorsi P, Andreini D (2020) Plaque quantification by coronary computed tomography angiography using intravascular ultrasound as a reference standard: a comparison between standard and last generation computed tomography scanners. Eur Heart J Cardiovasc Imaging 21(2):191–201

    PubMed  Google Scholar 

  34. CT Coronary Angiography (2015) Patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 385(9985):2383–2391

    Article  Google Scholar 

  35. Ferencik M, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Lu MT, Meyersohn NM, Ivanov AV, Adami EC, Patel MR, Mark DB, Udelson JE, Lee KL, Douglas PS, Hoffmann U (2018) Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE Randomized Clinical Trial. JAMA Cardiol 3(2):144–152

    Article  PubMed  PubMed Central  Google Scholar 

  36. Randomised Trial of Cholesterol Lowering (1994) 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344(8934):1383–1389

    Google Scholar 

  37. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brien E, Ostergren J (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361(9364):1149–1158

    Article  CAS  PubMed  Google Scholar 

  38. Daida H, Dohi T, Fukushima Y, Ohmura H, Miyauchi K (2019) The goal of achieving atherosclerotic plaque regression with lipid-lowering therapy: insights from IVUS trials. J Atheroscler Thromb 26(7):592–600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Stegman B, Shao M, Nicholls SJ, Elshazly M, Cho L, King P, Kapadia S, Tuzcu M, Nissen SE, Puri R (2016) Coronary atheroma progression rates in men and women following high-intensity statin therapy: a pooled analysis of REVERSAL, ASTEROID and SATURN. Atherosclerosis 254:78–84

    Article  CAS  PubMed  Google Scholar 

  40. Lee SE, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, Gottlieb I, Hadamitzky M, Kim YJ, Lee BK, Leipsic JA, Maffei E, Marques H, de Araujo Goncalves P, Pontone G, Raff GL, Shin S, Stone PH, Samady H, Virmani R, Narula J, Berman DS, Shaw LJ, Bax JJ, Lin FY, Min JK, Chang HJ (2019) Differences in progression to obstructive lesions per high-risk plaque features and plaque volumes With CCTA. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2019.09.011

  41. Andelius L, Mortensen MB, Norgaard BL, Abdulla J (2018) Impact of statin therapy on coronary plaque burden and composition assessed by coronary computed tomographic angiography: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 19(8):850–858

    Article  PubMed  Google Scholar 

  42. Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A (2016) Coronary plaque morphology and the anti-inflammatory impact of atorvastatin: a multicenter 18F-fluorodeoxyglucose positron emission tomographic/computed tomographic study. Circ Cardiovasc Imaging 9(12):e004195

    Article  PubMed  PubMed Central  Google Scholar 

  43. Lang S, Lacombe JM, Mary-Krause M, Partisani M, Bidegain F, Cotte L, Aslangul E, Cheret A, Boccara F, Meynard JL, Pradier C, Roger PM, Tattevin P, Costagliola D, Molina JM (2015) Is impact of statin therapy on all-cause mortality different in HIV-infected individuals compared to general population? Results from the FHDH-ANRS CO4 cohort. PLoS One 10(7):e0133358

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Mosepele M, Molefe-Baikai OJ, Grinspoon SK, Triant VA (2018) Benefits and risks of statin therapy in the HIV-infected population. Curr Infect Dis Rep 20(8):20

    Article  PubMed  PubMed Central  Google Scholar 

  45. Bernal E, Marin I, Masia M, Gutierrez F (2017) Statins in HIV-infected patients: potential beneficial effects and clinical use. AIDS Rev 19(2):59–71

    PubMed  Google Scholar 

  46. Lo J, Lu MT, Ihenachor EJ, Wei J, Looby SE, Fitch KV, Oh J, Zimmerman CO, Hwang J, Abbara S, Plutzky J, Robbins G, Tawakol A, Hoffmann U, Grinspoon SK (2015) Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lancet HIV 2(2):e52–e63

    Article  PubMed  PubMed Central  Google Scholar 

  47. Nou E, Lu MT, Looby SE, Fitch KV, Kim EA, Lee H, Hoffmann U, Grinspoon SK, Lo J (2016) Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV. Aids 30(4):583–590

    Article  CAS  PubMed  Google Scholar 

  48. Hoffmann U, Lu MT, Olalere D, Adami EC, Osborne MT, Ivanov A, Aluru JS, Lee S, Arifovic N, Overton ET, Fichtenbaum CJ, Aberg JA, Alston-Smith B, Klingman KL, Waclawiw M, Burdo TH, Williams KC, Zanni MV, Desvigne-Nickens P, Cooper-Arnold K, Fitch KV, Ribaudo H, Douglas PS, Grinspoon SK (2019) Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): effects of pitavastatin on coronary artery disease and inflammatory biomarkers. Am Heart J 212:1–12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Campbell JH, Efendy JL, Smith NJ, Campbell GR (2001) Molecular basis by which garlic suppresses atherosclerosis. J Nutr 131(3 s):1006s–1006s9s

    Article  CAS  PubMed  Google Scholar 

  50. Budoff MJ, Takasu J, Flores FR, Niihara Y, Lu B, Lau BH, Rosen RT, Amagase H (2004) Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: a preliminary study. Prev Med 39(5):985–991

    Article  PubMed  Google Scholar 

  51. Budoff MJ, Ahmadi N, Gul KM, Liu ST, Flores FR, Tiano J, Takasu J, Miller E, Tsimikas S (2009) Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med 49(2–3):101–107

    Article  CAS  PubMed  Google Scholar 

  52. Matsumoto S, Nakanishi R, Li D, Alani A, Rezaeian P, Prabhu S, Abraham J, Fahmy MA, Dailing C, Flores F, Hamal S, Broersen A, Kitslaar PH, Budoff MJ (2016) Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with metabolic syndrome in a prospective randomized double-blind study. J Nutr 146(2):427s–432s

    Article  CAS  PubMed  Google Scholar 

  53. Shaikh K, Kinninger A, Cherukuri L, Birudaraju D, Nakanishi R, Almeida S, Jayawardena E, Shekar C, Flores F, Hamal S, Sheikh MS, Johanis A, Cu B, Budoff MJ (2020) Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with diabetes: a randomized, double-blind, placebo-controlled study. Exp Ther Med 19(2):1457–1461

    PubMed  Google Scholar 

  54. Reiner Z (2013) Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. Nutr Metab Cardiovasc Dis 23(9):799–807

    Article  CAS  PubMed  Google Scholar 

  55. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 367(22):2089–2099

    Article  CAS  PubMed  Google Scholar 

  56. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A (2011) Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 378(9802):1547–1559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K, Moos MP, Kaiser B, Cohnert TU, Wahlers T, Zieske A, Plenz G, Robenek H, Salbach P, Kuhn H, Radmark O, Samuelsson B, Habenicht AJ (2003) Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100(3):1238–1243

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Tardif JC, L’Allier PL, Ibrahim R, Gregoire JC, Nozza A, Cossette M, Kouz S, Lavoie MA, Paquin J, Brotz TM, Taub R, Pressacco J (2010) Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. Circ Cardiovasc Imaging 3(3):298–307

    Article  PubMed  Google Scholar 

  59. Matsumoto S, Ibrahim R, Gregoire JC, L’Allier PL, Pressacco J, Tardif JC, Budoff MJ (2017) Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study. Clin Cardiol 40(4):210–215

    Article  PubMed  Google Scholar 

  60. Almeida SO, Ram RJ, Kinninger A, Budoff MJ (2020) Effect of 5-lipoxygenase inhibitor, VIA-2291 (Atreleuton), on epicardial fat volume in patients with recent acute coronary syndrome. J Cardiovasc Comput Tomogr. https://doi.org/10.1016/j.jcct.2019.12.033

  61. Papageorgiou N, Zacharia E, Ioannou A, Rehal O, Zacharias K, Siasos G, Tousoulis D (2016) Novel anti-platelets in stable coronary artery disease. Curr Pharm Des 22(29):4537–4567

    Article  CAS  PubMed  Google Scholar 

  62. Lee DH, Chun EJ, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S (2019) Effect of cilostazol, a phosphodiesterase-3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes: ESCAPE study. Diabetes Obes Metab 21(6):1409–1418

    Article  CAS  PubMed  Google Scholar 

  63. Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, Lopez-Sendon J, Ostadal P, Koenig W, Angoulvant D, Gregoire JC, Lavoie MA, Dube MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L’Allier PL, Guertin MC, Roubille F (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 381(26):2497–2505

    Article  CAS  PubMed  Google Scholar 

  64. Verma S, Eikelboom JW, Nidorf SM, Al-Omran M, Gupta N, Teoh H, Friedrich JO (2015) Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 15:96

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. Vaidya K, Arnott C, Martinez GJ, Ng B, McCormack S, Sullivan DR, Celermajer DS, Patel S (2018) Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: A CT coronary angiography study. JACC Cardiovasc Imaging 11(2 Pt 2):305–316

    Article  PubMed  Google Scholar 

  66. Armstrong EJ, Harskamp CT, Armstrong AW (2013) Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2(2):e000062

    Article  PubMed  PubMed Central  Google Scholar 

  67. Lerman JB, Joshi AA, Chaturvedi A, Aberra TM, Dey AK, Rodante JA, Salahuddin T, Chung JH, Rana A, Teague HL, Wu JJ, Playford MP, Lockshin BA, Chen MY, Sandfort V, Bluemke DA, Mehta NN (2017) Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study. Circulation 136(3):263–276

    Article  PubMed  PubMed Central  Google Scholar 

  68. Elnabawi YA, Dey AK, Goyal A, Groenendyk JW, Chung JH, Belur AD, Rodante J, Harrington CL, Teague HL, Baumer Y, Keel A, Playford MP, Sandfort V, Chen MY, Lockshin B, Gelfand JM, Bluemke DA, Mehta NN (2019) Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovasc Res 115(4):721–728

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Hjuler KF, Bottcher M, Vestergaard C, Botker HE, Iversen L, Kragballe K (2016) Association between changes in coronary artery disease progression and treatment with biologic agents for severe psoriasis. JAMA Dermatol 152(10):1114–1121

    Article  PubMed  Google Scholar 

  70. Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ (2014) Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis 73(10):1797–1804

    Article  PubMed  Google Scholar 

  71. Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O’Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Stork S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377(14):1319–1330

    Article  CAS  PubMed  Google Scholar 

  72. Beyer C, Wildauer M, Feuchtner G, Friedrich G, Hintringer F, Stuhlinger M, Plank F (2020) Relationship of anticoagulant therapies on coronary plaque progression: a longitudinal CTA analysis. JACC Cardiovasc Imaging 13(1 Pt 1):169–170

    Article  PubMed  Google Scholar 

  73. Barrett-Connor E, Khaw KT (1988) Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 78(3):539–545

    Article  CAS  PubMed  Google Scholar 

  74. Smith GD, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P (2005) Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112(3):332–340

    Article  CAS  PubMed  Google Scholar 

  75. Liverman C BD, (eds) (2004) Testosterone and aging Clinical research directions. The National Academies Press, Washington, DC

    Google Scholar 

  76. Budoff MJ, Ellenberg SS, Lewis CE, Mohler ER 3, Wenger NK, Bhasin S, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Nakanishi R, Nezarat N, Matsumoto S, Hou X, Basaria S, Diem SJ, Wang C, Cifelli D, Snyder PJ (2017) Testosterone treatment and coronary artery plaque volume in older men with low testosterone. Jama 317(7):708–716

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Nelson JR, Wani O, May HT, Budoff M (2017) Potential benefits of eicosapentaenoic acid on atherosclerotic plaques. Vascul Pharmacol 91:1–9

    Article  CAS  PubMed  Google Scholar 

  78. Urabe Y, Yamamoto H, Kitagawa T, Utsunomiya H, Tsushima H, Tatsugami F, Awai K, Kihara Y (2013) Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy. Circ J 77(10):2578–2585

    Article  CAS  PubMed  Google Scholar 

  79. Shintani Y TK (2012) The impact of a pure-EPA omega-3 fatty acid on coronary plaque stabilization: a plaque component analysis with 64-slice multi-detector row computed tomography [abstract]. J Am Coll Cardiol (59)

  80. Nagahara Y, Motoyama S, Sarai M, Ito H, Kawai H, Takakuwa Y, Miyagi M, Shibata D, Takahashi H, Naruse H, Ishii J, Ozaki Y (2016) Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease. Atherosclerosis 250:30–37

    Article  CAS  PubMed  Google Scholar 

  81. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369(9567):1090–1098

    Article  CAS  PubMed  Google Scholar 

  82. Alfaddagh A, Elajami TK, Ashfaque H, Saleh M, Bistrian BR (2017) Welty FK (2017) Effect of eicosapentaenoic and docosahexaenoic acids added to statin therapy on coronary artery plaque in patients with coronary artery disease: a randomized clinical trial. J Am Heart Assoc 6(12):6981

    Article  CAS  Google Scholar 

  83. Budoff MMJ, Bhatt DL, Le VT, May HT, Shaikh K, Shekar C, Kinniger A, Lakshmanan S, Roy S, Tayek J, Nelson JR (2019) Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy (EVAPORATE). American Heart Association, Chicago

    Google Scholar 

  84. Lakshmanan S, Shekar C, Kinninger A, Dahal S, Onuegbu A, Cai AN, Hamal S, Birudaraju D, Roy SK, Nelson JR, Budoff MJ, Bhatt DL (2020) Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography. Cardiovasc Res 116(3):479–482

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Lundquist Institute of Biomedical Research and Innovation, 1124 West Carson Street, Torrance, CA, 90502, USA

    Suvasini Lakshmanan, Vahid Rezvanizadeh & Matthew J. Budoff

Authors
  1. Suvasini Lakshmanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vahid Rezvanizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew J. Budoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew J. Budoff.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lakshmanan, S., Rezvanizadeh, V. & Budoff, M.J. Comprehensive plaque assessment with serial coronary CT angiography: translation to bedside. Int J Cardiovasc Imaging 36, 2335–2346 (2020). https://doi.org/10.1007/s10554-020-01849-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-020-01849-x

Keywords

Search

Navigation